Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -69.69 Thousand USD | 82.83% |
| 2022 | -405.88 Thousand USD | 22.46% |
| 2021 | -523.47 Thousand USD | 41.86% |
| 2020 | -900.29 Thousand USD | -4.09% |
| 2019 | -864.88 Thousand USD | 37.3% |
| 2018 | -1.37 Million USD | 6.61% |
| 2017 | -1.47 Million USD | 10.61% |
| 2016 | -1.65 Million USD | 20.66% |
| 2015 | -2.08 Million USD | 48.57% |
| 2014 | -4.04 Million USD | -63.77% |
| 2013 | -2.47 Million USD | 15.5% |
| 2012 | -2.92 Million USD | 38.76% |
| 2011 | -4.77 Million USD | -143.6% |
| 2010 | -1.96 Million USD | -71.87% |
| 2009 | -1.14 Million USD | 52.07% |
| 2008 | -2.38 Million USD | -300.89% |
| 2007 | -593.99 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -30.6 Thousand USD | 67.11% |
| 2024 Q2 | -10.03 Thousand USD | 67.2% |
| 2023 Q4 | -93.05 Thousand USD | -79.28% |
| 2023 Q1 | -30.41 Thousand USD | 73.88% |
| 2023 Q2 | 68.4 Thousand USD | 324.92% |
| 2023 Q3 | -51.9 Thousand USD | -175.88% |
| 2023 FY | -69.69 Thousand USD | 82.83% |
| 2022 FY | -405.88 Thousand USD | 22.46% |
| 2022 Q1 | -95.45 Thousand USD | 48.97% |
| 2022 Q2 | -122.36 Thousand USD | -28.19% |
| 2022 Q3 | -139.07 Thousand USD | -13.66% |
| 2022 Q4 | -116.44 Thousand USD | 16.27% |
| 2021 FY | -523.47 Thousand USD | 41.86% |
| 2021 Q3 | 3693.00 USD | 139.4% |
| 2021 Q4 | -187.06 Thousand USD | -5165.31% |
| 2021 Q2 | -9374.00 USD | 96.14% |
| 2021 Q1 | -242.91 Thousand USD | -21.24% |
| 2020 Q3 | -198.28 Thousand USD | 20.33% |
| 2020 Q1 | -174.94 Thousand USD | 20.83% |
| 2020 Q2 | -248.88 Thousand USD | -42.26% |
| 2020 Q4 | -200.36 Thousand USD | -1.05% |
| 2020 FY | -900.29 Thousand USD | -4.09% |
| 2019 Q3 | -209.6 Thousand USD | -13.12% |
| 2019 FY | -864.88 Thousand USD | 37.3% |
| 2019 Q1 | -180.29 Thousand USD | 62.59% |
| 2019 Q2 | -185.3 Thousand USD | -2.78% |
| 2019 Q4 | -220.99 Thousand USD | -5.43% |
| 2018 Q1 | -326.63 Thousand USD | 12.93% |
| 2018 FY | -1.37 Million USD | 6.61% |
| 2018 Q2 | -418.58 Thousand USD | -28.15% |
| 2018 Q4 | -481.95 Thousand USD | -216.7% |
| 2018 Q3 | -152.17 Thousand USD | 63.64% |
| 2017 Q3 | -428.4 Thousand USD | -18.76% |
| 2017 FY | -1.47 Million USD | 10.61% |
| 2017 Q4 | -375.13 Thousand USD | 12.43% |
| 2017 Q2 | -360.71 Thousand USD | -15.32% |
| 2017 Q1 | -312.79 Thousand USD | 35.83% |
| 2016 FY | -1.65 Million USD | 20.66% |
| 2016 Q4 | -487.45 Thousand USD | -46.87% |
| 2016 Q1 | -527.56 Thousand USD | -22.29% |
| 2016 Q3 | -331.89 Thousand USD | -8.69% |
| 2016 Q2 | -305.36 Thousand USD | 42.12% |
| 2015 Q1 | -724.18 Thousand USD | -2.49% |
| 2015 FY | -2.08 Million USD | 48.57% |
| 2015 Q3 | -506.79 Thousand USD | -20.59% |
| 2015 Q2 | -420.26 Thousand USD | 41.97% |
| 2015 Q4 | -431.4 Thousand USD | 14.88% |
| 2014 Q2 | -1.27 Million USD | -61.65% |
| 2014 Q4 | -706.57 Thousand USD | 44.92% |
| 2014 Q3 | -1.28 Million USD | -0.79% |
| 2014 Q1 | -787.37 Thousand USD | -20.14% |
| 2014 FY | -4.04 Million USD | -63.77% |
| 2013 Q2 | -647.82 Thousand USD | 2.24% |
| 2013 Q4 | -655.36 Thousand USD | -29.29% |
| 2013 Q3 | -506.9 Thousand USD | 21.75% |
| 2013 Q1 | -662.67 Thousand USD | -19.85% |
| 2013 FY | -2.47 Million USD | 15.5% |
| 2012 Q3 | -792.1 Thousand USD | 0.71% |
| 2012 Q2 | -797.73 Thousand USD | -1.83% |
| 2012 Q4 | -552.93 Thousand USD | 30.19% |
| 2012 Q1 | -783.43 Thousand USD | 8.74% |
| 2012 FY | -2.92 Million USD | 38.76% |
| 2011 Q1 | -828.62 Thousand USD | -10.12% |
| 2011 Q2 | -1.83 Million USD | -121.48% |
| 2011 Q3 | -1.14 Million USD | 37.39% |
| 2011 Q4 | -858.48 Thousand USD | 25.29% |
| 2011 FY | -4.77 Million USD | -143.6% |
| 2010 Q3 | -372.13 Thousand USD | 19.29% |
| 2010 Q2 | -461.07 Thousand USD | -22.63% |
| 2010 Q1 | -376 Thousand USD | -18.79% |
| 2010 FY | -1.96 Million USD | -71.87% |
| 2010 Q4 | -752.44 Thousand USD | -102.2% |
| 2009 FY | -1.14 Million USD | 52.07% |
| 2009 Q2 | -251.71 Thousand USD | 40.09% |
| 2009 Q3 | -153.02 Thousand USD | 39.21% |
| 2009 Q1 | -420.13 Thousand USD | 14.52% |
| 2009 Q4 | -316.51 Thousand USD | -106.84% |
| 2008 Q1 | -578.46 Thousand USD | 0.0% |
| 2008 Q4 | -491.5 Thousand USD | 35.64% |
| 2008 Q3 | -763.64 Thousand USD | -39.43% |
| 2008 FY | -2.38 Million USD | -300.89% |
| 2008 Q2 | -547.69 Thousand USD | 5.32% |
| 2007 FY | -593.99 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | 90.358% |
| IR-Med Inc. | -4.9 Million USD | 98.58% |
| Polarean Imaging plc | -11.88 Million USD | 99.414% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 117.65% |
| Avitar, Inc. | -2.25 Million USD | 96.916% |
| AVITA Medical, Inc. | -39.16 Million USD | 99.822% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 94.018% |
| Össur hf. | 58.38 Million USD | 100.119% |
| Zecotek Photonics Inc. | -3.51 Million USD | 98.02% |
| QHSLab, Inc. | -468.36 Thousand USD | 85.12% |
| Wellstar International, Inc. | -3.1 Million USD | 97.758% |
| Össur hf. | 58.38 Million USD | 100.119% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 102.963% |
| Escalon Medical Corp. | -125.26 Thousand USD | 44.363% |
| Aurora Spine Corporation | -1.68 Million USD | 95.853% |
| BrainsWay Ltd. | -4.19 Million USD | 98.34% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 99.394% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 88.519% |
| Vivos Inc. | -2.89 Million USD | 97.593% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.985% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 68.101% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 96.08% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 83.329% |
| Nanomix Corporation | -12.33 Million USD | 99.435% |
| Theraclion SA | -3.67 Million USD | 98.104% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 90.745% |
| Positron Corporation | -1.63 Million USD | 95.747% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 97.361% |
| Lombard Medical, Inc. | -31.03 Million USD | 99.775% |
| ALR Technologies Inc. | -11.89 Million USD | 99.414% |
| Stratec SE | 14.42 Million USD | 100.483% |
| Heart Tronics, Inc. | -13.32 Million USD | 99.477% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 44.481% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 99.503% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 99.73% |
| VMS Rehab Systems, Inc. | 46.44 USD | 150166.753% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 98.003% |
| Ingen Technologies, Inc. | -5.06 Million USD | 98.623% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 92.306% |
| United American Healthcare Corporation | 723 Thousand USD | 109.639% |
| ECGI Holdings, Inc. | -3.61 Million USD | 98.07% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 89.409% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 90.278% |
| Urologix, Inc. | -7.6 Million USD | 99.084% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 95.886% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 96.8% |
| SS Innovations International, Inc. | -20.94 Million USD | 99.667% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 91.343% |
| Smith & Nephew plc | 263 Million USD | 100.026% |
| NIOX Group Plc | 13.64 Million USD | 100.511% |
| Fuse Medical, Inc. | 1.45 Million USD | 104.773% |
| Broncus Holding Corporation | -28.09 Million USD | 99.752% |
| Brain Scientific Inc. | -12.34 Million USD | 99.435% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 99.762% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 56.511% |